About My Health Careers Internship MedBlogs Contact us

Economic Burden Of Dengue In Burkina Faso, Kenya, And Cambodia Studied

by Rishika Gupta on March 3, 2019 at 10:41 AM
Font : A-A+

 Economic Burden Of Dengue In Burkina Faso, Kenya, And Cambodia Studied

The average cost of inpatient care was found to be $26 in Burkina Faso and $134 in Cambodia, while the average cost of outpatient care was $13 per episode in Burkina Faso and $23 in Kenya. It was also found that the majority of the expenses were directly spent as out of pocket money by the patients.

Dengue fever is a major public health concern in many parts of South-East Asia and South America and its prevalence in Africa is thought to be expanding. Researchers have now analyzed the economic burden of dengue fever in Burkina Faso, Kenya, and Cambodia. Their results appear this week in PLOS Neglected Tropical Diseases.


Dengue fever is a vector-borne disease transmitted by Aedes mosquitos. While there are studies on the economic burden of dengue in some countries with high prevalence of the disease, countries in Africa had not previously been analyzed, and cost comparisons between countries are often not standardized.

In the new work, as part of the Dengue Vaccine Initiative (DVI) Jung-Seok Lee, and colleagues developed a patient-specific survey questionnaire on the cost of dengue and administered it to patients in six countries in a standardized manner. The survey included multiple interviews to capture both public and private (out-of-pocket costs). Data was previously published on the economic burden of dengue in Vietnam, Thailand, and Colombia; the new paper deals with the cost of the illness in Burkina Faso, Kenya and Cambodia.

Four hundred fourteen patients with dengue were identified at the field sites in Burkina Faso, 149 in Kenya, and 254 in Cambodia. The average cost of inpatient care was $26 in Burkina Faso and $134 in Cambodia, while the average cost of outpatient care was $13 per episode in Burkina Faso and $23 in Kenya. In both African countries, the majority of costs were directly borne by patients and the costs were not insignificant compared to the economic cost of malaria, a major pathogen in the areas.

"The economic burden outcomes presented in the current study can be used to estimate more accurate vaccination benefits when conducting a cost-effectiveness analysis of dengue fever vaccine interventions in the three countries in the future," the researchers say.

Source: Eurekalert

News A-Z
News Category
What's New on Medindia
First-Ever Successful Pig-To-Human Kidney Transplantation
World Osteoporosis Day 2021 -
Spirituality and Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Dengue Fever Dengue / Dengue Hemorrhagic Fever Mosquito Diseases Dengue and Homeopathy Chikungunya and Homeopathy Chikungunya Dengue Top 15 Doīs and Donīts for Preventing and Managing Dengue Fever Dengue Vaccine 

Recommended Reading
Higher The Dengue Infection Antibodies, Higher The Protection Against Zika
Antibodies created during Prior dengue infection could protect the body from the Zika virus, finds ....
Severity of Dengue can be Predicted Through 20 Genes
Researchers have identified 20 genes that can predict an individual's likelihood of developing a ......
Dengue Patients Should Defer from Donating Blood for 6-12 Months
Dengue and Chikungunya infected patients should not donate blood for 6-12 months. These infections ....
Patient With Severe Dengue Type Disorder Saved by Fortis Doctors
A 12-year-old boy from Gurugram got a new lease of life after doctors at the Fortis Hospital ......
Chikungunya is a viral disease spread by mosquito bites; it causes fever, severe joint pain and rash...
Dengue is a tropical disease caused by mosquitoes carrying the dengue virus. Symptoms include fever,...
Dengue / Dengue Hemorrhagic Fever
Encyclopedia section of medindia gives general information about Dengue and Dengue Hemorrhagic ......
Dengue Vaccine
Several dengue vaccines are under development. Dengvaxia, Sanofi’s live-attenuated tetravalent dengu...
Mosquito Diseases
Mosquito-borne diseases, like malaria, filaria, dengue, etc are common in places conducive of mosqu...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use